288 related articles for article (PubMed ID: 31000186)
21. A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population.
Rodríguez-Mañero M; López-Pardo E; Cordero A; Ruano-Ravina A; Novo-Platas J; Pereira-Vázquez M; Martínez-Gómez Á; García-Seara J; Martínez-Sande JL; Peña-Gil C; Mazón P; García-Acuña JM; Valdés-Cuadrado L; González-Juanatey JR
Int J Chron Obstruct Pulmon Dis; 2019; 14():371-380. PubMed ID: 30863038
[TBL] [Abstract][Full Text] [Related]
22. Retrospective cohort study of new-onset atrial fibrillation in acute pulmonary embolism on prognosis.
Liu D; Shi S; Liu X; Ye T; Wang L; Qu C; Yang B; Zhao Q
BMJ Open; 2021 Sep; 11(9):e047658. PubMed ID: 34551942
[TBL] [Abstract][Full Text] [Related]
23. Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias.
Konecny T; Park JY; Somers KR; Konecny D; Orban M; Soucek F; Parker KO; Scanlon PD; Asirvatham SJ; Brady PA; Rihal CS
Am J Cardiol; 2014 Jul; 114(2):272-7. PubMed ID: 24878126
[TBL] [Abstract][Full Text] [Related]
24. Effect of atrial fibrillation pattern on survival in a community-based cohort.
Keating RJ; Gersh BJ; Hodge DO; Weivoda PL; Patel PJ; Hammill SC; Shen WK
Am J Cardiol; 2005 Nov; 96(10):1420-4. PubMed ID: 16275191
[TBL] [Abstract][Full Text] [Related]
25. The association between relevant co-morbidities and prevalent as well as incident heart failure in patients with atrial fibrillation.
Wändell P; Carlsson AC; Holzmann MJ; Ärnlöv J; Sundquist J; Sundquist K
J Cardiol; 2018 Jul; 72(1):26-32. PubMed ID: 29358024
[TBL] [Abstract][Full Text] [Related]
26. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.
Raparelli V; Pastori D; Pignataro SF; Vestri AR; Pignatelli P; Cangemi R; Proietti M; Davì G; Hiatt WR; Lip GYH; Corazza GR; Perticone F; Violi F; Basili S;
Intern Emerg Med; 2018 Aug; 13(5):651-660. PubMed ID: 29582316
[TBL] [Abstract][Full Text] [Related]
27. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study.
Graul EL; Nordon C; Rhodes K; Menon S; Al Ammouri M; Kallis C; Ioannides AE; Whittaker HR; Peters NS; Quint JK
BMC Pulm Med; 2024 May; 24(1):221. PubMed ID: 38704538
[TBL] [Abstract][Full Text] [Related]
29. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.
Wang TJ; Larson MG; Levy D; Vasan RS; Leip EP; Wolf PA; D'Agostino RB; Murabito JM; Kannel WB; Benjamin EJ
Circulation; 2003 Jun; 107(23):2920-5. PubMed ID: 12771006
[TBL] [Abstract][Full Text] [Related]
30. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure.
Frasure-Smith N; Lespérance F; Habra M; Talajic M; Khairy P; Dorian P; Roy D;
Circulation; 2009 Jul; 120(2):134-40, 3p following 140. PubMed ID: 19564557
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and electrophysiological characteristics of typical atrial flutter in patients with atrial fibrillation and chronic obstructive pulmonary disease.
Hayashi T; Fukamizu S; Hojo R; Komiyama K; Tanabe Y; Tejima T; Nishizaki M; Hiraoka M; Ako J; Momomura S; Sakurada H
Europace; 2013 Dec; 15(12):1777-83. PubMed ID: 23787904
[TBL] [Abstract][Full Text] [Related]
32. Atrial fibrillation and chronic obstructive pulmonary disease: diagnostic sequence and mortality risk.
Warming PE; Garcia R; Hansen CJ; Simons SO; Torp-Pedersen C; Linz D; Tfelt-Hansen J
Eur Heart J Qual Care Clin Outcomes; 2023 Feb; 9(2):128-134. PubMed ID: 36069895
[TBL] [Abstract][Full Text] [Related]
33. Persistent atrial fibrillation as a prognostic factor of outcome in patients with advanced heart failure.
Wojtkowska I; Sobkowicz B; Musiał WJ; Kozuch M
Kardiol Pol; 2006 Aug; 64(8):777-83; discussion 784-5. PubMed ID: 16981052
[TBL] [Abstract][Full Text] [Related]
34. Change in lipid profile and risk of new-onset atrial fibrillation in patients with chronic heart failure: A 3-year follow-up observational study in a large Chinese hospital.
Liu C; Geng J; Ye X; Yuan X; Li A; Zhang Z; Xu B; Wang Y
Medicine (Baltimore); 2018 Sep; 97(39):e12485. PubMed ID: 30278536
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of new-onset atrial fibrillation associated with worsening heart failure in aging patients with severely decompensated acute heart failure.
Kiuchi K; Shirakabe A; Kobayashi N; Okazaki H; Matsushita M; Shibata Y; Goda H; Shigihara S; Asano K; Tani K; Hata N; Asai K; Shimizu W
Int J Cardiol; 2020 Mar; 302():88-94. PubMed ID: 31813678
[TBL] [Abstract][Full Text] [Related]
36. Chronic obstructive pulmonary disease predicts higher incidence and in hospital mortality for atrial fibrillation. An observational study using hospital discharge data in Spain (2004-2013).
Méndez-Bailón M; Lopez-de-Andrés A; de Miguel-Diez J; de Miguel-Yanes JM; Hernández-Barrera V; Muñoz-Rivas N; Lorenzo-Villalba N; Jiménez-García R
Int J Cardiol; 2017 Jun; 236():209-215. PubMed ID: 28190617
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of myocardial damage markers in patients with chronic heart failure with atrial fibrillation.
Otaki Y; Arimoto T; Takahashi H; Kadowaki S; Ishigaki D; Narumi T; Honda Y; Iwayama T; Nishiyama S; Shishido T; Miyashita T; Miyamoto T; Watanabe T; Kubota I
Intern Med; 2014; 53(7):661-8. PubMed ID: 24694473
[TBL] [Abstract][Full Text] [Related]
38. Low atrial fibrillatory rate is associated with poor outcome in patients with mild to moderate heart failure.
Platonov PG; Cygankiewicz I; Stridh M; Holmqvist F; Vazquez R; Bayes-Genis A; McNitt S; Zareba W; de Luna AB;
Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):77-83. PubMed ID: 22235036
[TBL] [Abstract][Full Text] [Related]
39. High molecular weight fibroblast growth factor-2 as a promising prognostic biomarker to predict the occurrence of heart failure in atrial fibrillation patients.
Sun LY; Qu X; Chen LZ; Chen XX; Zheng GS; Wang ZT; Huang WJ; Zhou H
Heart Vessels; 2017 Dec; 32(12):1506-1512. PubMed ID: 28689282
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion.
Tükek T; Yildiz P; Akkaya V; Karan MA; Atilgan D; Yilmaz V; Korkut F
Ann Noninvasive Electrocardiol; 2002 Jul; 7(3):222-7. PubMed ID: 12167183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
